Shire competitors

Shire Competitors include Sanofi Genzyme, Amgen, Gilead Sciences, Celgene, Biogen and Vertex Pharmaceuticals.
Add company...
Shire
Shire
Shire is a specialty biopharmaceutical company.
Sanofi Genzyme
Sanofi Genzyme
Sanofi Genzyme focuses on developing specialty treatments for debilitating diseases that are often difficult to diagnose and treat, providing hope to patients and their families.
Amgen
Amgen
Amgen engages in the development of human therapeutic products in supportive of cancer care, inflammation, nephrology and bone diseases.
Gilead Sciences
Gilead Sciences
Gilead Sciences is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines.
Celgene
Celgene
Celgene Corporation is a biopharmaceutical company.
Biogen
Biogen
Biogen develops, markets and manufactures therapies for people living with serious neurological, autoimmune and rare diseases.
Vertex Pharmaceuticals
Vertex Pharmaceuticals
Vertex Pharmaceuticals is focused on the discovery and development of small molecule drugs for the treatment of serious diseases.
Founding Date
Founding Date
1986
Founding Date
1981
Founding Date
1980
Founding Date
1987
Founding Date
1986
Founding Date
1978
Founding Date
1989
Type
Type
Public
Type
Subsidiary
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Dublin, IE HQ
Buenos Aires, AR
Sydney, AU
Wien, AT
Bruxelles, BE
Chácara Santo Antonio (Zona Sul), BR
Sofia, BG
see more
Locations
Cambridge, US HQ
Locations
Thousand Oaks, US HQ
Sydney, AU
North Ryde, AU
Vienna, AT
Brussels, BE
São Paulo, BR
Mississauga, CA
see more
Locations
Foster City, US HQ
Seattle, US
San Dimas, US
Oceanside, US
Fremont, US
Branford, US
Locations
Summit, US HQ
Singapore, SG
Boudry, CH
Locations
Cambridge, US HQ
Locations
Boston, US HQ
Employees
Employees
23,044
Employees
N/A
Employees
20,800
Employees
10,00011% increase
Employees
7,467
Employees
7,300
Employees
2,300
Valuation ($)
Valuation ($)
53.4 b
Valuation ($)
N/A
Valuation ($)
122.4 b
Valuation ($)
84.8 b
Valuation ($)
47.7 b
Valuation ($)
63.4 b
Valuation ($)
43.5 b
Twitter followers
Twitter followers
6.2 k
Twitter followers
N/A
Twitter followers
65.4 k
Twitter followers
27 k
Twitter followers
19.1 k
Twitter followers
19.4 k
Twitter followers
32.9 k

Financial

Revenue (est.)
Revenue (est.)
£52.3m (FY, 2017)
Revenue (est.)
$5b (Y, 2017)
Revenue (est.)
$22.8b (FY, 2017)
Revenue (est.)
$26.1b (FY, 2017)
Revenue (est.)
$13b (FY, 2017)
Revenue (est.)
$11.4b (FY, 2016)
Revenue (est.)
$2.5b (FY, 2017)
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$4.1b (FY, 2017)
Cost of goods
$4.4b (FY, 2017)
Cost of goods
$461m (FY, 2017)
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
N/A
Gross profit
$18.8b (FY, 2017)
Gross profit
$21.7b (FY, 2017)
Gross profit
$12.5b (FY, 2017)
Gross profit
N/A
Gross profit
N/A
Net income
Net income
£3.1m (FY, 2017)
Net income
N/A
Net income
$2b (FY, 2017)
Net income
$4.6b (FY, 2017)
Net income
$2.9b (FY, 2017)
Net income
$3.7b (FY, 2016)
Net income
$91.6m (FY, 2017)

Operating

Countries
Countries
100 (FY, 2017)
Countries
100 (Sep, 2018)
Countries
N/A
Countries
30 (FY, 2016)
Countries
N/A
Countries
N/A
Countries
N/A
Phase I Trials Products
Phase I Trials Products
7 (FY, 2017)
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
3 (FY, 2016)
Phase I Trials Products
N/A
Phase I Trials Products
4 (FY, 2016)
Phase I Trials Products
N/A
Phase II Trials Products
Phase II Trials Products
10 (FY, 2017)
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
12 (FY, 2016)
Phase II Trials Products
N/A
Phase II Trials Products
10 (FY, 2016)
Phase II Trials Products
N/A
Phase III Trials Products
Phase III Trials Products
15 (FY, 2017)
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
6 (FY, 2016)
Phase III Trials Products
N/A
Phase III Trials Products
2 (FY, 2016)
Phase III Trials Products
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 175.5m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 2.4m
For sources of this data, please see the company profileDownload Excel

View company profiles

Sanofi Genzyme
HQ
Cambridge, US

Sanofi Genzyme focuses on developing specialty treatments for debilitating diseases that are often difficult to diagnose and treat, providing hope to patients and their families.

View company
Amgen
HQ
Thousand Oaks, US
Employees
20,800

Amgen engages in the development of human therapeutic products in supportive of cancer care, inflammation, nephrology and bone diseases.

View company
Gilead Sciences
HQ
Foster City, US
Employees
10,000↑ 11% increase

Gilead Sciences is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines.

View company
Celgene
HQ
Summit, US
Employees
7,467

Celgene Corporation is a biopharmaceutical company.

View company